Health begins at home

Denosumab-bnht (Conexxence, Bomyntra) became the third biosimilar in 2025 to be approved for denosumab (Prolia, Xgeva).

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

The new approval is an oral suspension for patients with hypertension and left ventricular hypertrophy and for the treatment of diabetic nephropathy.

The event will focus on clinical practice expansion for community pharmacies and how to make them a revenue-generating health care destination.